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Background: Protective lung ventilation is recommended in
patients with acute respiratory distress syndrome (ARDS) to mini-
mize additional injuries to the lung. However, hypercapnic acidosis
resulting from ventilation at lower tidal volume enhances pulmo-
nary hypertension and might induce right ventricular (RV) failure.
We investigated if extracorporeal veno-venous CO2 removal therapy
could have beneficial effects on pulmonary circulation and RV
function.
Methods: This study was performed on an experimental model of
ARDS obtained in eight anaesthetized pigs connected to a volume-
cycled ventilator. A micromanometer-tipped catheter was inserted
into the main pulmonary artery and an admittance micr-
omanometer-tipped catheter was inserted into the right ventricle.
RV–arterial coupling was derived from RV pressure-volume loops.
ARDS was obtained by repeated bronchoalveolar lavage. Protective
ventilation was then achieved, and the pigs were connected to a
pump-driven extracorporeal membrane oxygenator (PALP, Maquet,
Germany) in order to achieve CO2 removal.
Results: ARDS induced severe hypercapnic acidosis. Systolic pul-
monary artery pressure significantly increased from 29.6 ± 1.8 to
43.9 ± 2.0 mmHg (P < 0.001). After the PALP was started, acidosis
was corrected and normocarbia was maintained despite protective
ventilation. Pulmonary artery pressure significantly decreased to
31.6 ± 3.2 mmHg (P < 0.001) and RV–arterial coupling significantly
improved (RV–arterial coupling index = 1.03 ± 0.33 vs. 0.55 ± 0.41,
P < 0.05).
Conclusion: Veno-venous CO2 removal therapy enabled protective
ventilation while maintaining normocarbia during ARDS. CO2
removal decreased pulmonary hypertension and improved RV func-
tion. This technique may be an effective lung- and RV-protective
adjunct to mechanical ventilation.
Editorial comment: what this article tells us
In adult respiratory distress syndrome, hypercarbia and increased pulmonary vascular resistance can
place strain on the right heart. The findings in this large animal experimental model show that
extracorporeal carbon dioxide elimination in this setting can lead to improvement in pulmonary
vascular resistance and right ventricular–arterial coupling.
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Acute respiratory distress syndrome (ARDS) is
responsible for injuries to the alveolar epithelium
and microvascular endothelium, which result in
severe hypoxemia, decreased pulmonary compli-
ance, and increased pulmonary vascular resis-
tance (PVR).1,2 Acute pulmonary hypertension
increases right ventricular (RV) afterload.
Positive-pressure ventilation, required to correct
ARDS-induced hypoxemia, further increases pul-
monary hypertension and RV afterload, leading to
acute cor pulmonale and RV failure.3,4 Moreover,
mechanical ventilation induces additional lung
injuries due to overdistention, repeated stretch to
the alveoli, and increased inflammatory mediator
levels.5–7 Despite new strategies in mechanical
ventilation, ARDS continues to be a devastating
disease.8 Mortality rates for ARDS decreased over
time but still remain around 40%, which, in large
part, is caused by hemodynamic complications to
this syndrome.9,10 In order to reduce deleterious
effects of positive-pressure ventilation, pro-
tective ventilation strategies have been devel-
oped, showing improvement in the outcome of
mechanically ventilated patients. The ARDSnet
investigators reported a 25% reduction in mortal-
ity with a ventilation strategy involving limita-
tion of mean tidal volume to 6 ml/kg, as
compared with a more traditional tidal volume of
12 ml/kg.11 However, low tidal volumes required
by such ventilation strategies increase hypercap-
nia associated to ARDS. Most clinicians seldom
use very low tidal volumes in practice because of
the clinical acceptability of this ‘permissive’
hypercapnia. Indeed, despite some potential ben-
eficial anti-inflammatory effects, it is well estab-
lished that hypercapnic acidosis (HCA) has
deleterious effects, in particular by contributing
to increase constriction within the pulmonary
vasculature.4,12–14
Thus, modern care for ARDS requires decision
to maximally reduce ventilator settings to ensure
lung protection and reduce exacerbation of lung
injury while facing the deleterious consequences
of this intervention. In order to supplement or
replace the lung function and to avoid ventilator-
induced lung injury, gas exchange via an extra-
corporeal device has been developed.15 Such a
device may make it possible to avoid mechanical
ventilation altogether in selected patients.16
Extracorporeal membrane oxygenation (ECMO)
allows blood oxygenation and carbon dioxide
(CO2) removal but requires high blood flow and,
as a result, placement of large cannulas. More-
over, this technique is too costly for routine use as
a lung rest strategy in adult ARDS patients.15
When compared with oxygenation, removal of
CO2 from blood can be accomplished at lower
blood flows. Indeed, due to its high solubility and
diffusing capacity in blood, high amount of CO2
can be removed from a venous blood sample as
compared with the small amount of oxygen that
can be added.17,18 As a result, less invasive veno-
venous devices have been specifically designed
for CO2 removal with high gas exchange effi-
ciency at relatively low blood flow rates (400–
1500 ml/min). The invasiveness of these devices,
called ‘low flow extracorporeal veno-venous CO2
removal therapy (ECCO2RT)’, is reduced by use
of percutaneous dual lumen catheters, compa-
rable with catheterization for dialysis. The aim of
our study was to determine if ECCO2RT used at
early stage of ARDS could have beneficial effects
on pulmonary circulation and improve RV func-
tion in a pig model.
Material and methods
All experimental procedures and protocols used
in this investigation were reviewed and approved
by the ethical committee of the Medical Faculty of
the University of Liege and conformed to the Guide
for the Care and Use of Laboratory Animals published
by the US National Institutes of Health (NIH pub-
lication no. 85-23, revised 1996). Primary end
points were changes in pulmonary artery pressure
(PAP) and RV–arterial coupling. Experiments
were performed from November 2013 to April
2014 on eight healthy pure Pietran pigs of either
sex, weighing from 21 to 33 kg. The animals were
premedicated with intramuscular administration
of tiletamine (250 mg) and zolazepam (250 mg).
Anesthesia was then induced and maintained by
a continuous infusion of sufentanil (0.5 μg/kg/h)
and pentobarbital (5 mg/kg/h). Spontaneous
movements were prevented by cisatracurium
bésilate (0.5 mg/kg/h). After endotracheal intu-
bation via a cervical tracheostomy, the pigs were
connected to a volume-cycled ventilator (Servo
300, Maquet, Rastatt, Germany) set to deliver a
tidal volume of 10 ml/kg at a respiratory rate of
20 breaths/min with an inspired O2 fraction
(FiO2) of 0.5 and an end-expiratory pressure of
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5 cm H2O. End-tidal CO2 measurements (Cap-
nomac, Datex, Helsinki, Finland) were used to
monitor the adequacy of ventilation. The pulmo-
nary trunk was exposed via a median sternotomy.
A micromanometer-tipped catheter (Scisense,
London, Canada) was inserted into the main pul-
monary artery through a stab wound in the RV
outflow tract in order to measure PAP. Pressure in
the left auricle (Pla) was measured with a micro-
manometer-tipped catheter (Scisense) inserted
into the cavity through the left atrial appendage.
Systemic arterial blood pressure (SAP) was moni-
tored via a micromanometer-tipped catheter (Sci-
sense) inserted into the aorta through the left
carotid artery. RV volume was measured from
admittance catheterization.19 A 5-F, 5-electrode
admittance micromanometer-tipped catheter (Sci-
sense) was inserted through the RV infundibu-
lum into the RV and positioned so that all
electrodes were in the RV cavity. A central venous
line was inserted into the right jugular vein and
placed inside the superior vena cava. A 4F fluid-
filled catheter (Pulsiocath, Pulsion Medical
System, Munich, Germany) was inserted into the
right femoral artery for pulse pressure analysis. A
6F Fogarty balloon catheter (Baxter Healthcare
Corp., Oakland, CA, USA) was advanced into the
inferior vena cava through a right femoral
venotomy. Inflation of this balloon produced a
gradual preload reduction.
Experimental protocol
After surgical preparation, the animals were
allowed to stabilize for 60 min (‘baseline state’).
Baseline hemodynamic recording was performed,
including PAP, Pla, mean arterial blood pressure,
and heart rate (HR). ARDS was achieved by
repeated bronchoalveolar lavage (37°C, 60 ml/kg
of 0.9% saline solution). Ventilator settings were
reduced to achieve ‘protective ventilation’ (tidal
volume = 6 ml/kg) after the induction of ARDS.
When PaO2/FiO2 was < 200 and PaCO2 >
60 mmHg, hemodynamic recording was per-
formed (‘ARDS state’) and ECCO2RT was started.
Hemodynamic recording was repeated after
30 min of ECCO2RT (‘ECCO2RT state’). ECCO2RT
was stopped after 60 min. A last hemodynamic
recording was performed 30 min after ECCO2RT
was stopped (‘OFF state’). Arterial blood gas
analysis was performed at each stage of the
experiment. End-tidal CO2 was continuously
monitored. Fluid administration with Hartmann’s
solution was continuously controlled by preload
responsiveness. When pulse pressure variation
was ≤ 11%, animals were considered as
adequately filled. A warming blanket and a
heated operating table were used to prevent
hypothermia.
Description and insertion of the ECCO2RT
ECCO2RT was achieved with the PALP module
(Cardiohelp, Maquet), which consists of a unit in
which gas exchange and pump take place with an
integrated control console. The system was inter-
faced with the pig through an inflow catheter
(13F) inserted into the inferior vena cava and an
outflow catheter (10F) inserted into the superior
vena cava. The pump withdrew venous blood
from the inferior vena cava, which, after CO2
removal, was re-infused into the right atrium
through the superior vena cava. The PALP unit
was primed with 345 ml of normal saline. Plastic
tubing provided by the manufacturer was imme-
diately connected to each venous catheter, and the
PALP unit was started. Pump speed was adjusted
to reach an aspiration pressure of 60 mmHg and
sweep gas flow was set to the maximum value
(10 l/min).
Heparin bolus was given before the PALP con-
nection and assessed by the activated clotting
time (ACT; in seconds) using a Hemochron Sig-
nature Microcoagulation System (International
Technidyne, Edison, NJ, USA). The target ACT
was 180 s.
Data collection
All analog signals were continuously digitized
and recorded (Notocord, Paris, France): HR (beats
per minute), SAP (mmHg), PAP (mmHg), Pla
(mmHg), RV end-systolic volume (ml), and RV
end-diastolic volume (ml). PALP blood flow
(l/min) was directly recorded from the PALP
console.
Arterial tension of oxygen (PaO2, mmHg), CO2
(PaCO2, mmHg), and arterial pH were measured
at each stage of the experiment (Baseline, ARDS,
ECCO2RT, OFF).
Extravascular lung water (EVLW) and pulmo-
nary vascular permeability index (PVPI) were
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measured using a transpulmonary thermodilution
method at baseline, after ARDS and at the end of
the experiment.20 Transpulmonary thermodilu-
tion was not performed during PALP therapy
because of the right atrium reinfusion.
Data analysis
Maximal and minimal PAP defined systolic and
diastolic pressures, respectively. Systolic ejection
interval (ts) was measured from the foot of the
pulmonary arterial pressure wave to its incisura,
and the diastolic interval was td = T – ts, where T
is the cardiac cycle length. Pulmonary blood flow
(PBF) was derived from RV stroke volume given
by RV admittance catheter and HR. RV contractil-
ity was assessed by end-systolic elastance (Ees).
The slope of the end-systolic pressure (ESP)–
volume relation was obtained from transient
occlusions of the inferior vena cava using the
Fogarty balloon, during apnea. Pulmonary arte-
rial elastance (Ea) was assessed from the ratio of
RV ESP minus Pla to RV stroke volume (SV).
Mean PVR was calculated as the ratio of mean
PAP minus Pla divided by PBF.
Statistical analysis
Changes in hemodynamic parameters and blood
gas data at each stage of the experiment were
evaluated by a repeated-measures analysis of
variance followed by Scheffé post-hoc tests. Cor-
relation analysis was performed using Pearson’s
correlation coefficient. Data were expressed as
mean ± standard deviation.
Results
EVLW and PVPI increased during ARDS
(229 ± 95 ml to 441 ± 95 ml, P < 0.01 and from
2.21 ± 0.49 to 4.40 ± 0.49, P < 0.001, respectively).
Arterial blood gases and acid-base equilibrium
during the experiment are depicted in Table 1.
Appropriate hypercapnia was obtained in all
pigs. When compared with baseline, mean PaCO2
more than doubled during the ARDS, returned to
baseline when the PALP was started, and
increased again when ECCO2RT was stopped.
PaO2 decreased during ARDS. The arterial pH
decreased during ARDS, returned to normal
values during ECCO2RT, and decreased again
when the PALP was stopped.
Hemodynamic data are depicted in Table 2.
The amount of fluid (Hartmann’s solution)
used to achieve adequate filling was
1.08 ± 0.18 l. Mean blood flow in the PALP was
645 ± 84 ml/min. Systolic PAPs increased by
more than half during ARDS, decreased during
ECCO2RT, and increased again after the PALP
was stopped (Figs 1 and 2). Changes in PAPs
were highly correlated with changes in PaCO2
(r = 0.87) and with changes in pH (r = −0.84)
resulting from PALP therapy. Changes in PAPs
were poorly correlated with changes in PaO2
due to PALP therapy (r = −0.55). Similarly,
PVR increased during ARDS, decreased during
ECCO2RT, and increased again after the
PALP was stopped (Table 2). Cardiac index
(CI) and Pla did not change during the whole
experiment. SV decreased during ARDS and
increased during PALP therapy. Ea near doubled
during ARDS, returned to normal values during
ECCO2RT and increased again when the
PALP was stopped (Fig. 3). RV contractility,
assessed with Ees, increased when the PALP
was stopped (Fig. 3). Ventriculo–arterial cou-
pling, assessed by the ratio of Ees on Ea
decreased under the unit during ARDS, come
back at or around the unit during ECCO2RT and
decreased again when the PALP was stopped
(Fig. 3).
Table 1 Arterial blood gas data.
PaO2 (mmHg) PaCO2 (mmHg) pH Hemoglobin (g/dl) Temperature
Baseline 178,8 ± 42† 41,7 ± 3,6† 7,44 ± 0.05† 9,2 ± 1.2 36,6 ± 0.4
ARDS 54,7 ± 12,3* 78,6 ± 8,1* 7,13 ± 0.05* 9,7 ± 1.3 36,6 ± 0.6
ECCO2RT 72,2 ± 21,0* 39,8 ± 5,6† 7,36 ± 0.05† 8,6 ± 0,8 36,3 ± 0.4
OFF 61,1 ± 15,12* 70,5 ± 11,2* 7,15 ± 0.05* 8,8 ± 0,7 36,0 ± 0.5
*Signiﬁcant difference vs. baseline at P < 0.05; †Signiﬁcant difference vs. ARDS at P < 0.05. All data are means ± standard deviation. Basal, baseline
conditions; ARDS, acute respiratory distress syndrome; ECCO2RT, extracorporeal CO2 removal therapy; OFF, stop of extracorporeal CO2 removal.
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Table 2 Hemodynamic data.
HR sAP CI SV Pla PAPm PVR Ea Ees Ees/Ea
Baseline 73 ± 11† 104 ± 25 2,11 ± 0,59 30,1 ± 10,6† 7,5 ± 1.9 19,8 ± 3,9† 6,57 ± 3,50† 1,12 ± 0,42† 0,93 ± 0,25 0.92 ± 0,27†
ARDS 103 ± 25* 105 ± 11 2,29 ± 0.48 21,7 ± 5,3* 6,5 ± 3,9 32,8 ± 6,2* 11,92 ± 3,40* 1,99 ± 0,45* 0,99 ± 0,42 0,52 ± 0,20*
ECCO2RT 82 ± 17 91 ± 11 2,58 ± 0.67 32,0 ± 9,2† 8,1 ± 1,9 23,8 ± 4,5† 6,76 ± 3,36† 1,08 ± 0,42† 0,95 ± 0.22 0,98 ± 0,27†
OFF 76 ± 11 95 ± 11 2,24 ± 0.45 28,1 ± 6,4 9,1 ± 2,1 32,7 ± 7,0* 11,56 ± 5,68* 1,88 ± 0,76* 1,05 ± 0,31 0,60 ± 0,14*
*Signiﬁcant difference vs. baseline at P < 0.05; †signiﬁcant difference vs. ARDS at P < 0.05. All data are means ± standard deviation. HR, heart rate;
sAP (mmHg), systolic arterial pressure (mmHg); CI (l/min/m2), cardiac index; SV (ml), stroke volume; Pla (mmHg), left atrial pressure; PAPm (mmHg),
mean pulmonary arterial pressure; PVR(mmHg/min/l/m2), indexed mean pulmonary vascular resistance; Ea (mmHg/ml), pulmonary arterial elas-
tance; Ees (mmHg/ml), RV end-systolic elastance; Ees/Ea, RV ventriculo–arterial coupling index. Basal, baseline conditions; ARDS, acute respiratory
distress syndrome; ECCO2RT, extracorporeal CO2 removal therapy; OFF, stop of extracorporeal CO2 removal.
Fig. 1. Evolution of systolic pulmonary artery
pressure (PAPs). *Signiﬁcant difference vs.
baseline at P < 0.05, #signiﬁcant difference vs.
ARDS at P < 0.05. Baseline, baseline
conditions; ARDS, acute respiratory distress
syndrome; ECCO2RT, extracorporeal CO2
removal therapy; OFF, stop of extracorporeal
CO2 removal.
Fig. 2. Example of the time course of systolic
pulmonary artery pressure (PAPs). Baseline,
baseline conditions; ARDS, acute respiratory
distress syndrome; ECCO2RT, extracorporeal
CO2 removal therapy; OFF, stop of
extracorporeal CO2 removal.
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Discussion
This is the first study precisely analyzing the
respiratory and hemodynamic effects of CO2
removal with an extravascular device in an
experimental model of ARDS. The findings were:
1. CO2 removal during ARDS with the PALP
device was very effective to achieve normocar-
bia and to normalize acidosis, while maintain-
ing protective ventilation.
2. Pulmonary vascular tone was significantly
reduced and RV–arterial coupling was improv-
ed during ECCO2RT.
Artificial lung support systems are medical
devices designed to supplement or replace the
respiratory function of the natural lung. ECMO
was introduced for treatment of neonatal respira-
tory failure. ECMO is an effective but costly and
very invasive technique for selected patients with
severe pulmonary failure. ECMO requires highly
trained staff and is currently used in adults only
in a few centers. Several simpler devices have
been developed allowing a reduction in minute
ventilation, reduced airway pressure, improved
PaO2-to-FIO2 ratio, and improved survival in
animal models of ARDS. Recently, Batchinsky
et al. demonstrated that such simpler devices can
provide a 50% reduction in minute ventilation
while maintaining normocarbia and may be an
effective lung-protective adjunct to mechanical
ventilation.21 Our results showed that the PALP
device was efficient for CO2 removal during
ARDS, enabling lung protective ventilation at
low tidal volume. Alteration of the permeability
of the alveolar-capillary membrane during ARDS
was demonstrated by impaired gas exchanges and
increased PVPI.22 The device achieved correction
of HCA in less than 15 min in all pigs. The PALP
technology uses the same technique as ECMO
and is composed of a centrifugal pump, a micro-
porous hollow-fiber oxygenator, two venous can-
nulas, and tubing. The gas exchange membrane is
very efficient and specifically designed for CO2
removal with low resistance to blood flow.
However, as compared with ECMO, cannulas are
substantially smaller with almost the same size as
dialysis cannulas.
The main finding of our study was a significant
reduction in PAP and PVR during ECCO2RT. This
reduction was clearly related to the correction of
HCA. HCA enhances pulmonary vasoconstric-
tion.12,23 Several clinical studies demonstrated
that HCA causes an increase in mean PAP in
ARDS.4,24,25 Our study is concordant with those
findings with a significant increase in PAP during
ARDS. However, the relative roles of hypercapnia
and acidosis in the mechanism of pulmonary
vasoconstriction remain unclear. Acute PHT
increases RV afterload,26,27 which individually
Fig. 3. Evolution of pulmonary arterial
elastance (Ea, mmHg/ml), RV end-systolic
elastance (Ees, mmHg/ml) and RV
ventriculo–arterial coupling index (Ees/Ea).
Signiﬁcant differences: *Signiﬁcant difference
vs. baseline at P < 0.05, #signiﬁcant difference
vs. ARDS at P < 0.05. Baseline, baseline
conditions; ARDS, acute respiratory distress
syndrome; ECCO2RT, extracorporeal CO2
removal therapy; OFF, stop of extracorporeal
CO2 removal; RV, right ventricular.
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and collectively with microvascular obstruction
effects of positive-pressure ventilation, and HCA
exacerbate RV failure in ARDS.4 Acute cor pulmo-
nale in ARDS patients is associated with high
mortality rates.28 Impaired RV function at early
stage of ARDS may be underdiagnosed, and yet it
might be the harbinger of a downward spiral in
the patient’s condition.4 We previously estab-
lished that PVR and RV ejection fraction are poor
indicators of RV–arterial performance.26 RV–
arterial coupling is beneficial for cardiovascular
performance and is assessed by the ratio of Ees
to Ea, where Ees and Ea characterize the RV
system and the pulmonary vascular system,
respectively.29 Ees precisely determines the con-
tractility of the right ventricle independently of
the loading conditions, and Ea is a precise
measure of RV afterload. Indeed, afterload is not
only characterized by PVR, but also results from a
dynamic interplay among resistance, compliance,
and wave reflection.26 The ratio of Ees to Ea
reflects the mechano-energetic aspects of
RV–vascular coupling. It can be demonstrated
that efficiency of energy transfer from the RV to
the pulmonary circulatory system is optimal
when Ees/Ea = 2, whereas RV stroke work is
maximal when Ees/Ea = 1. However, when Ees/
Ea < <1, there is a mismatch between RV contrac-
tility and pulmonary vascular load.29 In ARDS
patients, increased RV afterload is responsible for
increased Ea, whereas Ees may decrease because
of HCA, hypoxia, and often associated sepsis,
leading to uncoupling between the right ventricle
and the pulmonary circulation, and finally pre-
cipitating RV failure.30 Therapies should be
ideally oriented to restore the coupling between
the heart and pulmonary vasculature by avoiding
any increase in pulmonary vascular tone as well
as depression in RV contractility.24,30 Our study
showed that Ea was significantly increased
during ARDS and was significantly reduced
during ECCO2RT. The effects of HCA on myocar-
dial function are contradictory. Acidosis decreases
myocardial contractility because hydrogen ions
inhibit Ca2+ influx into the myocardial fiber.31
However, hypercapnia causes coronary vasodila-
tation leading to better myocardial perfusion and
performance.32 We did not observe significant
changes in Ees during ARDS and during
ECCO2RT. During ARDS, the animals were
unable to maintain an optimal ventriculo–arterial
coupling despite a trend to increase RV contrac-
tility, and Ees/Ea ratio dropped below the unit.
The ECCO2RT, however, helped to restore a ratio
around the unit mainly by lowering Ea. When the
PALP was stopped, we again observed an
RV–arterial coupling index (Ees/Ea ratio) lower
than the unit. Uncoupling between RV and pul-
monary arterial system resulted in decreased SV,
whereas CO did not change because of increased
HR.
In ARDS, pulmonary vasoconstriction may not
result only from HCA, but also from other factors
like hypoxia or inflammatory mechanisms.
Hypoxic pulmonary vasoconstriction is a widely
conserved, homeostatic, and adaptive vasomotor
response to alveolar hypoxia, which redistributes
blood to optimally ventilated lung segments by
an active process of vasoconstriction.33,34 This
response to hypoxia is strongly enhanced when
HCA is superimposed.34 Conversely, improved
blood oxygenation without changes in alveolar
oxygenation should not affect PVR. However,
changes in PaCO2 indirectly influenced changes
in alveolar oxygenation by the alveolar gas equa-
tion, and this mechanism could have played a role
in pulmonary vasomotor tone.34 In our study,
changes in PaO2 due to ECCO2RT were non-
significant and poorly correlated with changes in
PAP, whereas changes in PaCO2 and pH were
highly significant and highly correlated with
changes in PAP. Similarly, when the PALP was
stopped, pulmonary vasoconstriction occurred
again, whereas PaO2 did not significantly change.
Blood temperature slightly, but non-
significantly, decreased along the experiment.
Hemoglobin tended to decrease during PALP
therapy, which may be explained by hemodilu-
tion resulting from the priming of the device
(Table 1). As a result, neither temperature nor
hemoglobin changes should have significantly
influenced CO2 exchanges during the experiment.
Others methodological issues should be taken
into account: The experimental model of ARDS
used in this study is different from ARDS
observed in human beings. Although injury to the
pulmonary circulation has been clearly demon-
strated in human ARDS,35,36 our model induced
lung injury without direct aggression to the pul-
monary vasculature, allowing this study to focus
on the effects of hypercapnia on pulmonary circu-
lation and RV function.
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In conclusion, use of the PALP device for
ECCO2RT in a pig model of ARDS allowed pro-
tective ventilation while maintaining normocar-
bia. The PALP device made it possible to rapidly
initiate extracorporeal lung support with a rela-
tively low invasive extracorporeal lung support
technology, thus avoiding ventilator-induced
barotrauma, which should have been necessary to
limit hypercapnia. Moreover, this device showed
beneficial hemodynamic effects by reducing pul-
monary vascular constriction related to HCA in
ARDS. The beneficial effect on Ea improved
RV–arterial coupling and consequently RV func-
tion in this experimental model of ARDS.
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